Abstract
International Journal of Therapy and RehabilitationVol. 21, No. 1 ResearchCommentaryKonstantine BalakatounisKonstantine BalakatounisSearch for more papers by this authorKonstantine BalakatounisPublished Online:20 Apr 2014https://doi.org/10.12968/ijtr.2014.21.1.17AboutSectionsView articleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareShare onFacebookTwitterLinked InEmail View article References Fleuren JF, Voerman GE, Erren-Wolters CV, Snoek GJ, Rietmar JS, Hermens HJet al. (2010) Stop using the Ashworth Scale for the assessment of spasticity. J Neurol Neurosurg Psychiatry 81(1): 46–52 Crossref, Google ScholarAbolhasani H, Ansari NN, Naghdi S, Mansouri K, Ghotbi N, Hasson S (2012) Comparing the validity of the Modified Modified Ashworth Scale (MMAS) and the Modified Tardieu Scale (MTS) in the assessment of wrist flexor spasticity in patients with stroke: protocol for a neurophysiological study. BMJ Open 19: 2(6) Google ScholarMehrholz J, Wagner K, Meissner D, Grundmann K, Zange C, Koch Ret al. (2005) Reliability of the Modified Tardieu Scale and the Modified Ashworth Scale in adult patients with severe brain injury: a comparison study. Clin Rehabil 19(7): 751–9 Crossref, Google ScholarRoyal College of Physicians (RCP), British Society of Rehabilitation Medicine, Chartered Society of Physiotherapy and Association of Chartered Physiotherapist Interested in Neurology (2009) Spasticity in adults: management using botulinum toxin. RCP, London Google ScholarTurner-Stokes L, Fheodoroff K, Jacinto J, Maisonobe P, Zakine B. (2013) Upper limb international spasticity study: rationale and protocol for a large, international, multicentre prospective cohort study investigating management and goal attainment following treatment with botulinum toxin A in real-life clinical practice. BMJ Open 18: 3(3) Google ScholarShaw L, Rodgers H, Price C, van Wijck F, Shackley P, Steen Net al. (2010) BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A. Health Technol Assess 14(26): 1–113, iii–iv Crossref, Google Scholar FiguresReferencesRelatedDetails 1 January 2014Volume 21Issue 1ISSN (online): 1759-779X Metrics History Published online 20 April 2014 Published in print 1 January 2014 Information© MA Healthcare LimitedPDF download
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have